BAJAJ BROKING

Notification
No new Notification messages
Divine Hira Jewellers IPO is Open!
Apply for the Divine Hira Jewellers IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
shukra pharmaceuticals limited stock

Shukra Pharmaceuticals Limited Share Price

245.7 -5.00 (-1.99%)
Mar 18 2025 03:15 PM Pharmaceuticals NSE: SHUKRAPHAR

Shukra Pharmaceuticals Limited Share Price Update

As of the latest trading session, Shukra Pharmaceuticals Limited share price is currently at 245.7, which is down by -5.00 from its previous closing. Today, the stock has fluctuated between 245.70 and 245.70. Over the past year, Shukra Pharmaceuticals Limited has achieved a return of 251.31 %. In the last month alone, the return has been 23.77 %. Read More...

Shukra Pharmaceuticals Limited Performance

Day Range

Low245.70 High245.70
245.70

52 Week Range

Low 57.52 High 271.50
245.70

Shukra Pharmaceuticals Limited Share Price

524632

SHUKRAPHAR

img img img img
No Data Available

Open Price

245.70

Prev. Close

250.70

Volume (Shares)

8776.00

Total traded value

21.56

Upper Circuit

250.60

Lower Circuit

240.80

Note: The current prices & values are delayed, Login to your account for live updates.

Shukra Pharmaceuticals Limited Fundamentals


(Standalone)

Market Cap (Cr) 1075.90
PE Ratio (TTM) 134.06
Book Value / Share 12.39
Beta -0.23
ROE 44.71%
EPS (TTM) 1.87
Dividend Yield 0.10%
Net Profit Qtr (Cr) 3.16

Shukra Pharmaceuticals Limited Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 10.58
Operating Expense 7.49
Net Profit 3.16
Net Profit Margin (%) 29.86
Earnings Per Share (EPS) 0.72
EBITDA 4.94
Effective Tax Rate (%) 22.73
Particulars SEP 2024 (Values in Cr)
Revenue 5.56
Operating Expense 5.70
Net Profit 0.54
Net Profit Margin (%) 9.71
Earnings Per Share (EPS) 0.12
EBITDA 1.68
Effective Tax Rate (%) 39.08
Particulars JUN 2024 (Values in Cr)
Revenue 3.18
Operating Expense 3.10
Net Profit 0.49
Net Profit Margin (%) 15.40
Earnings Per Share (EPS) 0.11
EBITDA 1.53
Effective Tax Rate (%) 38.74
Particulars MAR 2024 (Values in Cr)
Revenue 10.88
Operating Expense 7.04
Net Profit 3.99
Net Profit Margin (%) 36.67
Earnings Per Share (EPS) 3.64
EBITDA 5.81
Effective Tax Rate (%) 23.75
Particulars DEC 2023 (Values in Cr)
Revenue 18.89
Operating Expense 9.93
Net Profit 9.42
Net Profit Margin (%) 49.86
Earnings Per Share (EPS) 8.61
EBITDA 10.11
Effective Tax Rate (%) 1.15
Particulars MAR 2024 (Values in Cr)
Revenue 74.57
Operating Expense 57.51
Net Profit 18.54
Net Profit Margin (%) 24.86
Earnings Per Share (EPS) 16.93
EBITDA 22.22
Effective Tax Rate (%) 6.79
Particulars MAR 2023 (Values in Cr)
Revenue 58.83
Operating Expense 55.59
Net Profit 4.41
Net Profit Margin (%) 7.49
Earnings Per Share (EPS) 11.23
EBITDA 6.56
Effective Tax Rate (%) 0.90
Particulars MAR 2022 (Values in Cr)
Revenue 20.49
Operating Expense 19.55
Net Profit 0.75
Net Profit Margin (%) 3.66
Earnings Per Share (EPS) 4.79
EBITDA 2.96
Effective Tax Rate (%) 26.47
Particulars MAR 2021 (Values in Cr)
Revenue 11.20
Operating Expense 11.26
Net Profit 0.03
Net Profit Margin (%) 0.26
Earnings Per Share (EPS) 0.22
EBITDA 1.60
Effective Tax Rate (%) 60.00
Particulars MAR 2020 (Values in Cr)
Revenue 11.85
Operating Expense 11.78
Net Profit 0.04
Net Profit Margin (%) 0.33
Earnings Per Share (EPS) 0.23
EBITDA 1.65
Effective Tax Rate (%) 82.35
Particulars MAR 2024 (Values in Cr)
Book Value / Share 52.65
ROE % 44.71
ROCE % 44.16
Total Debt to Total Equity 0.10
EBITDA Margin 29.80
Particulars MAR 2023 (Values in Cr)
Book Value / Share 64.63
ROE % 21.18
ROCE % 18.84
Total Debt to Total Equity 0.20
EBITDA Margin 11.15
Particulars MAR 2022 (Values in Cr)
Book Value / Share 104.43
ROE % 4.69
ROCE % 5.81
Total Debt to Total Equity 0.41
EBITDA Margin 14.49
Particulars MAR 2021 (Values in Cr)
Book Value / Share 99.63
ROE % 0.90
ROCE % 1.35
Total Debt to Total Equity 0.57
EBITDA Margin 16.07
Particulars MAR 2020 (Values in Cr)
Book Value / Share 98.43
ROE % 0.13
ROCE % 0.36
Total Debt to Total Equity 0.46
EBITDA Margin 11.29
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 9.98
Total Assets 77.83
Total Liabilities 77.83
Total Equity 57.63
Share Outstanding 10959725
Price to Book Ratio 6.20
Return on Assets (%) 23.81
Return on Capital (%) 30.49
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 3.97
Total Assets 74.96
Total Liabilities 74.96
Total Equity 25.29
Share Outstanding 1565700
Price to Book Ratio 0.73
Return on Assets (%) 5.87
Return on Capital (%) 14.51
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.28
Total Assets 35.11
Total Liabilities 35.11
Total Equity 16.35
Share Outstanding 1565700
Price to Book Ratio 0.58
Return on Assets (%) 2.13
Return on Capital (%) 3.81
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.50
Total Assets 35.60
Total Liabilities 35.60
Total Equity 15.59
Share Outstanding 1565675
Price to Book Ratio 0.45
Return on Assets (%) 0.52
Return on Capital (%) 0.74
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.12
Total Assets 33.54
Total Liabilities 33.54
Total Equity 15.41
Share Outstanding 1565675
Price to Book Ratio 0.47
Return on Assets (%) 0.10
Return on Capital (%) 0.15
Particulars MAR 2024 (Values in Cr)
Net Income 19.88
Cash from Operations -4.57
Cash from Investing -1.20
Cash from Financing 12.40
Net change in Cash 6.00
Free Cash Flow -2.81
Particulars MAR 2023 (Values in Cr)
Net Income 4.44
Cash from Operations 3.41
Cash from Investing -4.42
Cash from Financing 4.94
Net change in Cash 3.68
Free Cash Flow 7.91
Particulars MAR 2022 (Values in Cr)
Net Income 1.01
Cash from Operations 8.42
Cash from Investing -1.52
Cash from Financing -6.67
Net change in Cash -0.21
Free Cash Flow 9.97
Particulars MAR 2021 (Values in Cr)
Net Income 0.09
Cash from Operations 0.53
Cash from Investing -1.89
Cash from Financing 1.73
Net change in Cash 0.37
Free Cash Flow 2.32
Particulars MAR 2020 (Values in Cr)
Net Income 0.17
Cash from Operations 1.23
Cash from Investing -3.11
Cash from Financing 1.99
Net change in Cash 0.12
Free Cash Flow 4.46
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 35.42 19.04 1.93 271.44 34.11 / 77.70
BLISS GVS PHARMA LTD 112.50 14.74 1.17 1185.42 92.25 / 184.95
CIPLA LTD 1493.05 24.17 4.25 120580.95 1317.60 / 1702.00
FERMENTA BIOTECH LIMITED 249.90 20.70 2.53 735.48 145.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2692.50 53.40 27.26 45612.57 1825.05 / 3087.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 35.42 21.34 6.02 271.44 34.11 / 77.70
AMRUTAJAN HEALTH LTD 587.10 34.41 5.69 1697.34 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 7719.65 115.13 28.40 19299.13 4050.15 / 8139.85
BLISS GVS PHARMA LTD 112.50 14.61 1.15 1185.42 92.25 / 184.95

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 244.00
  • 26 Days 227.20
  • 10 Days 239.40
  • 50 Days 206.30
  • 12 Days 237.70
  • 100 Days 169.70
  • 20 Days 231.70
  • 200 Days 132.10
250.70
PIVOT
First Resistance 250.70
Second Resistance 250.70
Third Resistance 250.70
First Support 250.70
Second Support 250.70
Third Support 250.70
RSI 65.10
MACD 10.50
Commodity Channel Index (CCI) 92.48
ADX 22.50
Williams % R -23.74

Over 1 Month

down

23.77

Over 3 Months

down

185.08

Over 6 Months

down

293.81

Over 1 Year

down

251.31

Over 3 Years

down

331.51

Over 5 Years

down

152.55

Shukra Pharmaceuticals Limited Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

Shukra Pharmaceuticals Limited Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
48.92
Promoter Holdings
50.95
FII
0.0
DII
0.11
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Yogesh Biharilal Parikh Public Shareholding 8400000.0 19.18
Renuka Yogesh Parikh Public Shareholding 8400000.0 19.18
Anar Project Private Limited Shareholding of Promoter and Promoter Group 8224000.0 18.78
Parshva Texchem India Private Ltd. Shareholding of Promoter and Promoter Group 7517560.0 17.17
Navkar Surgical Gujarat Shareholding of Promoter and Promoter Group 5160000.0 11.78
Dakshesh Rameshchandra Shah Shareholding of Promoter and Promoter Group 436000.0 1.0
Anar Jayeshbhai Patel Shareholding of Promoter and Promoter Group 436000.0 1.0
Sujay Jyotindra Mehta Shareholding of Promoter and Promoter Group 312000.0 0.71
Payal Sujay Mehta Shareholding of Promoter and Promoter Group 228000.0 0.52

Shukra Pharmaceuticals Limited

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-09-15 0.5 Final 2023-09-16 Equity shares 2022-09-22 0.5 Final 2022-09-22 Equity shares 2019-09-19 0.5 Final 2019-09-21 Equity shares 2018-08-31 0.5 Final 2018-09-04 Equity shares 2017-09-01 0.5 Final 2017-09-05 Equity shares
Ex-Date Ex-Bonus Ratio
2024-04-20 2024-04-19 3:1
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About Shukra Pharmaceuticals Limited

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by Shukra Pharmaceuticals Limited

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Shukra Pharmaceuticals Ltd?

Answer Field

The share price of Shukra Pharmaceuticals Ltd for NSE is ₹ 0.00 and for BSE is ₹ 245.70.

What is the Market Cap of Shukra Pharmaceuticals Ltd?

Answer Field

The market cap of Shukra Pharmaceuticals Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 10,75.90 Cr. as of now.

What is the 52 Week High and Low of Shukra Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Shukra Pharmaceuticals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 271.50 and ₹ 57.52.

How to Buy Shukra Pharmaceuticals Ltd share?

Answer Field

You can trade in Shukra Pharmaceuticals Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Shukra Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been 251.31%.

What is the Current Share Price of Shukra Pharmaceuticals Ltd?

Answer Field

Shukra Pharmaceuticals Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 245.70 as on Mar 18 2025 03:15 PM.

What is the Market Cap of Shukra Pharmaceuticals Ltd Share?

Answer Field

The market cap of Shukra Pharmaceuticals Ltd for NSE ₹ 0.0 & for BSE ₹ 10,75.90 as on Mar 18 2025 03:15 PM.

What is the P/E Ratio of Shukra Pharmaceuticals Ltd Share?

Answer Field

As on Mar 18 2025 03:15 PM the price-to-earnings (PE) ratio for Shukra Pharmaceuticals Ltd share is 134.06.

What is the PB ratio of Shukra Pharmaceuticals Ltd Share?

Answer Field

As on Mar 18 2025 03:15 PM, the price-to-book (PB) ratio for Shukra Pharmaceuticals Ltd share is 12.39.

How to Buy Shukra Pharmaceuticals Ltd Share?

Answer Field

You can trade in Shukra Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Shukra Pharmaceuticals Ltd Share on Bajaj Broking App?

Answer Field

To buy Shukra Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Shukra Pharmaceuticals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

9 lakh+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300+ Cr MTF Book

icon-with-text
loader